Shenzhen Kangtai Biological Products Co., Ltd. (300601.SZ)
Develops and sells vaccines for diseases like pneumonia, COVID-19, and measles in China.
12.28+0.02%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-30.2%
The outlook
Kangtai Biological is trading near the lower end of its 52-week range, with analyst sentiment leaning bearish overall. The average analyst price target sits roughly 34% above the current price, though the stock's valuation metrics appear stretched with a trailing P/E of 175.4. Price momentum is mixed relative to moving averages.
What’s behind the score
Price trendMixed vs its moving averages
52-week range15% of the way from its 52-week low to high
Price targetAvg target +34% vs current price
Analyst price target
~12-month · 3 analysts16.44average target+33.9% vs now
Now 12.28
Low 15.00High 18.82
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$13.72B
52-wk high
21.12
52-wk low
10.70
50-day avg
12.11
200-day avg
14.44
Trailing P/E
175.4